Sign In
Buy TKAI
$0.610
+0 (+0%)
At Close: Jan 16, 2018
Tokai Pharmaceuticals Announces Clinical Update
07:00am, Tuesday, 26'th Jul 2016
BOSTON--(BUSINESS WIRE)--Tokai Pharmaceuticals Inc. (NASDAQ:TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally d
